2017
DOI: 10.1371/journal.pone.0186429
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda – Moving towards elimination

Abstract: IntroductionThe incidence of gambiense human African trypanosomiasis (gHAT) in Uganda has been declining, from 198 cases in 2008, to only 20 in 2012. Interruption of transmission of the disease by early diagnosis and treatment is core to the control and eventual elimination of gHAT. Until recently, the format of available screening tests had restricted screening and diagnosis to central health facilities (passive screening). We describe a novel strategy that is contributing to elimination of gHAT in Uganda thr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
71
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 48 publications
(73 citation statements)
references
References 35 publications
2
71
0
Order By: Relevance
“…In 2013, a new passive surveillance strategy was implemented which saw the number of facilities participating in passive surveillance increase from four to 212 and subsequently adjusted to 170. The majority of facilities conduct only serological surveillance using a rapid diagnostic test (RDT) and 12 accept referrals of RDT positive patients for confirmation by microscopy (24).…”
Section: Scale Back In the Context Of Human African Trypanosomiasismentioning
confidence: 99%
See 2 more Smart Citations
“…In 2013, a new passive surveillance strategy was implemented which saw the number of facilities participating in passive surveillance increase from four to 212 and subsequently adjusted to 170. The majority of facilities conduct only serological surveillance using a rapid diagnostic test (RDT) and 12 accept referrals of RDT positive patients for confirmation by microscopy (24).…”
Section: Scale Back In the Context Of Human African Trypanosomiasismentioning
confidence: 99%
“…Plans to scale back the number of passive surveillance sites operating RDTs are ongoing in Uganda, with the target of ensuring that by 2030, >50% of at-risk populations should live within 1-hour of a health facility with HAT diagnostics and >95% should live within 5-hours (25). The number of health facilities using HAT RDTs were reviewed in July 2014 and September 2015, in response to the evolving epidemiological situation of g-HAT in Uganda (24). Previous analyses utilised the Euclidean distance to facilities as opposed to estimates of travel time.…”
Section: Scale Back In the Context Of Human African Trypanosomiasismentioning
confidence: 99%
See 1 more Smart Citation
“…In addition to integrating data from sentinel sites, the ability to receive transmitted patient results from remote laboratories is being exploited by some human African trypanosomiasis control programmes [47]. Beyond reduced turn-around time, post-analytic data transfer to the field opens the possibility of placing powerful information in the hands of care-givers at the point of care, such as real-time cumulative AST results according to region or health centre, or modular treatment guidelines informed by local epidemiology and accounting for tests available at the point of care in a given area.…”
Section: Diagnostic Preparedness For Outbreaks Of Infectious Diseasementioning
confidence: 99%
“…As cases of HAT recede in many areas of Africa today, this more costly active approach to case detection and treatment has given way to 'passive' case detection approaches which test only people with suggestive symptoms and rely on cases being detected during peoples' routine interactions with HCWs in health facilities. The recent development of rapid diagnostic tests (RDTs) for HAT, moreover, has enabled passive detection strategies to be reformed [10]. As with other RDTs, their ease of use means the first screening test in a step-wise algorithm can be taken out of hospital laboratories into primary care settings, broadening the pool of diagnosers able to test patients when they suspect disease.…”
Section: Introductionmentioning
confidence: 99%